OVA Conjugated Interleukin 8 Receptor Beta (IL8Rb) Mus musculus (Mouse) Conjugated small molecules

CD182; CDw128b; IL8R-B; IL8-RB; CMKAR2; CXCR2; IL8R2; C-X-C chemokine receptor type 2; GRO/MGSA receptor; High affinity interleukin-8 receptor B

Add to Cart Distributors
Overview
Properties
  • SourceProtein Conjugation
  • Original Molecular Massn/a
  • Buffer FormulationPBS, pH7.4.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Pointn/a
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • OVA Conjugated Interleukin 8 Receptor Beta (IL8Rb) Packages (Simulation)
  • OVA Conjugated Interleukin 8 Receptor Beta (IL8Rb) Packages (Simulation)
  • OVA Conjugated Interleukin 8 Receptor Beta (IL8Rb)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Formula

Usage

Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.pubmed:28900508
  • Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranesPubmed: 30679689
  • Pathogenic Functions of Tumor Necrosis Factor Receptor-associated Factor 6 Signaling following Traumatic Brain Injury
  • The neuroprotection of hyperbaric oxygen therapy against traumatic brain injury via NF-¦ÊB/MAPKs-CXCL1 signaling pathway

Recommend products